HK1026910A1 - Steroid sulfamates, method for the production and use thereof - Google Patents

Steroid sulfamates, method for the production and use thereof

Info

Publication number
HK1026910A1
HK1026910A1 HK00104311A HK00104311A HK1026910A1 HK 1026910 A1 HK1026910 A1 HK 1026910A1 HK 00104311 A HK00104311 A HK 00104311A HK 00104311 A HK00104311 A HK 00104311A HK 1026910 A1 HK1026910 A1 HK 1026910A1
Authority
HK
Hong Kong
Prior art keywords
group
atoms
alkyl
present
alkoxy
Prior art date
Application number
HK00104311A
Other languages
English (en)
Inventor
Helmut Kasch
Winfried Schumann
Johannes Roemer
Joerg Steinbach
Original Assignee
Sterix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterix Ltd filed Critical Sterix Ltd
Publication of HK1026910A1 publication Critical patent/HK1026910A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HK00104311A 1997-03-25 2000-07-12 Steroid sulfamates, method for the production and use thereof HK1026910A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19712488A DE19712488A1 (de) 1997-03-25 1997-03-25 Steroidsulfamate, Verfahren zu ihrer Herstellung und Anwendung derselben
PCT/DE1998/000813 WO1998042729A2 (fr) 1997-03-25 1998-03-18 Sulfamate de steroide, procede de production et utilisation de cette substance

Publications (1)

Publication Number Publication Date
HK1026910A1 true HK1026910A1 (en) 2000-12-29

Family

ID=7824559

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00104311A HK1026910A1 (en) 1997-03-25 2000-07-12 Steroid sulfamates, method for the production and use thereof

Country Status (9)

Country Link
US (1) US6339079B1 (fr)
EP (2) EP0970104B1 (fr)
JP (3) JP3746075B2 (fr)
AT (1) ATE346081T1 (fr)
CA (1) CA2284750C (fr)
DE (2) DE19712488A1 (fr)
ES (1) ES2276463T3 (fr)
HK (1) HK1026910A1 (fr)
WO (1) WO1998042729A2 (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6476011B1 (en) * 1991-08-28 2002-11-05 Sterix Limited Methods for introducing an estrogenic compound
US20040127473A1 (en) * 1996-12-05 2004-07-01 Reed Michael John Compound
DE19712488A1 (de) * 1997-03-25 1998-10-01 Knoell Hans Forschung Ev Steroidsulfamate, Verfahren zu ihrer Herstellung und Anwendung derselben
GB2331988B (en) 1997-12-04 2003-04-16 Imperial College Polycyclic sulphamate inhibitors or oestrone sulphatase
JP2000309599A (ja) 1999-04-13 2000-11-07 Kyowa Hakko Kogyo Co Ltd エストラ−１，３，５（１０），１６−テトラエン誘導体
DE10006155B4 (de) * 1999-06-24 2004-08-05 Forschungszentrum Rossendorf E.V. Verfahren zur Herstellung von 16α-[18F] Fluorestradiolsulfamaten
DE19943708B4 (de) * 1999-09-08 2007-12-20 Bayer Schering Pharma Ag Neue C13-substituierte Estra-1,3,5(10)-trien-3-yl-sulfamate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
US6583130B1 (en) 1999-09-13 2003-06-24 Schering Ag C13-substituted estra-1,3,5,(10)-trien-3-yl sulfamates, methods of preparing same, and pharmaceutical compositions containing these compounds
AU2190601A (en) * 1999-12-13 2001-06-25 Sterix Limited Halogenated sulphamate-, phosphonate-, thiophosphonate-, sulphonate- and sulphonamide- compounds as inhibitors of steroid sulphatase
US7335650B2 (en) 2000-01-14 2008-02-26 Sterix Limited Composition
WO2001081364A1 (fr) * 2000-04-24 2001-11-01 Kyowa Hakko Kogyo Co., Ltd. Derives d'estra-1,3,5(10)-triene
DE10027887A1 (de) † 2000-05-31 2001-12-13 Jenapharm Gmbh Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
GB0020498D0 (en) * 2000-08-18 2000-10-11 Sterix Ltd Compound
GB0113920D0 (en) * 2001-06-07 2001-08-01 Sterix Ltd Composition
US8026229B2 (en) 2001-08-13 2011-09-27 Sterix Limited Antitumor-active 2-alkoxyestradiol sulfamates
GB0201400D0 (en) * 2002-01-22 2002-03-13 Glaxo Group Ltd Novel apparatus and process
DE10307104A1 (de) 2003-02-19 2004-09-23 Schering Ag Antitumor wirksame 2-substituierte Estra-1,3,5(10)-trien-3-yl sulfamate
DE10307105A1 (de) * 2003-02-19 2004-09-09 Schering Ag Antitumor wirksame 2-substituierte 18a-Homoestra-1,3,5(10)-trien-3-yl sulfamate
DE10307103A1 (de) * 2003-02-19 2004-09-09 Schering Ag Antitumor wirksame 2-substituierte D-Homostra-1,3,5(10)-trien-3-yl sulfamate
DE102004025985A1 (de) * 2004-05-21 2005-12-15 Schering Ag Estriol- und Estetrol-Prodrugs
US20050282793A1 (en) * 2004-05-21 2005-12-22 Ralf Wyrwa Steroid prodrugs with androgenic action
DE102004025966A1 (de) * 2004-05-21 2005-12-15 Schering Ag Estradiol-Prodrugs
DE102004025986A1 (de) * 2004-05-21 2005-12-15 Schering Ag Steroid-Prodrugs mit androgener Wirkung
US7534780B2 (en) 2004-05-21 2009-05-19 Bayer Schering Pharma Aktiengesellschaft Estradiol prodrugs
GB0511190D0 (en) * 2005-06-01 2005-07-06 Sterix Ltd Use
US20070123500A1 (en) * 2005-11-29 2007-05-31 Gerd Mueller Prodrugs of ERbeta-selective substances, processes for their preparation and pharmaceutical compositions comprising these compounds
US20070197488A1 (en) * 2005-11-29 2007-08-23 Olaf Peters Prodrugs of ERbeta-selective substances, process for their production, and pharmaceutical compositions that contain these compounds
GB0624105D0 (en) * 2006-12-01 2007-01-10 Sterix Ltd Use
RU2678845C1 (ru) * 2018-11-08 2019-02-04 Ильясов Шамиль Сионович ПРИМЕНЕНИЕ 3-О-СУЛЬФАМОИЛОКСИ-7β-МЕТИЛ-D-ГОМО-6-ОКСАЭСТРА-1,3,5(10),8(9)-ТЕТРАЕН-17а-ОНА ДЛЯ ЛЕЧЕНИЯ РАКА МОЛОЧНОЙ ЖЕЛЕЗЫ, ВКЛЮЧАЯ ТРИЖДЫ НЕГАТИВНУЮ ФОРМУ

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2426777A1 (de) * 1974-05-31 1975-12-18 Schering Ag 1.3-oxygenierte 8 alpha-oestratriene
DK132707C (da) * 1973-07-13 1976-07-12 Schering Ag Analogifremgangsmade til fremstilling af 1,3,16,17-tetraoxygenerede 8alfa-ostratriener
US3951959A (en) * 1973-07-13 1976-04-20 Schering Aktiengesellschaft 1,3-Oxygenated 8α-estratrienes
GB9118478D0 (en) * 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
DE4429398C2 (de) * 1994-08-09 1997-09-11 Jenapharm Gmbh Verwendung von Estra-1,3,5(10)-trien-Derivaten zur hormonalen Kontrazeption
DE4429397C2 (de) 1994-08-09 2003-11-20 Jenapharm Gmbh Estra-1,3,5(10)-trien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE19540233B4 (de) * 1995-10-19 2005-08-25 Schering Ag Sulfamat-Derivate von 1,3,5(10)-Estratrien-Derivaten, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE19548449A1 (de) * 1995-12-22 1997-06-26 Jenapharm Gmbh 17alpha-Cyanomethyl-3-oxyiminoestra-4,9-dien-3-on-17beta-yl-derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE19712488A1 (de) * 1997-03-25 1998-10-01 Knoell Hans Forschung Ev Steroidsulfamate, Verfahren zu ihrer Herstellung und Anwendung derselben

Also Published As

Publication number Publication date
JP2009215317A (ja) 2009-09-24
CA2284750A1 (fr) 1998-10-01
EP1772462A3 (fr) 2012-05-16
JP2004123757A (ja) 2004-04-22
EP1772462A2 (fr) 2007-04-11
CA2284750C (fr) 2009-09-08
EP0970104B1 (fr) 2006-11-22
JP3746075B2 (ja) 2006-02-15
US6339079B1 (en) 2002-01-15
DE19712488A1 (de) 1998-10-01
JP2001507365A (ja) 2001-06-05
EP0970104A2 (fr) 2000-01-12
DE59813821D1 (de) 2007-01-04
WO1998042729A3 (fr) 1999-01-14
ES2276463T3 (es) 2007-06-16
WO1998042729A2 (fr) 1998-10-01
ATE346081T1 (de) 2006-12-15

Similar Documents

Publication Publication Date Title
HK1026910A1 (en) Steroid sulfamates, method for the production and use thereof
AU4806197A (en) Method and potentiated composition for treating migraine
BG106301A (en) Quinuclidine derivatives and their use as muscarinic m3 receptor ligands
IT1251376B (it) Pregna 1,4-diene-3,20-dione-16,17-acetal-21-esteri, procedimento per la loro preparazione, composizione e metodi per il trattamento di stati infiammatori
AU3009392A (en) 17-spirofuran-3'-ylidene steroids
HU9201190D0 (en) Method for producing new pregna-1,4-diene-3,20-dione derivatives
JPS5395922A (en) Preparation of dialkylchlorosilane
TW243446B (fr)
TW227001B (fr)
DE3360418D1 (en) Panel valve
EP0276393A3 (en) Process for the preparation of 6-alpha, 9-alpha-difluoro-11-beta-17-alpha-dihydroxy-16-alpha-methyl-pregn-4-ene-3,20-dione and its derivatives
JPS543372A (en) Electric floor polisher
JPS53145004A (en) Preventive apparatus against motor-noise
DE60131253D1 (de) 6-oxygenierte steroid-estrogene mit aromatischen a- und b-ringen
JPS543741A (en) Method of mounting door mirror
JPS5762300A (en) 17alpha-cyanosteroid
JPS5425407A (en) Fixing device for motor
JPS5244055A (en) Underground tank
JPS6444451A (en) Electrophotographic sensitive body
HUT68172A (en) Process for the preparation of substituted d, l-2-(7-fluoro-3,4-dihidro-3-oxo-2h-1,4-benzoxazin-6-yl)-perhydroimidazo[1,5-a]pyridine-1,3-diones
JPS6434985A (en) Indolo(6,5,4-cd)indole derivative
JPS5390586A (en) Remote change device of tool
JPS52139052A (en) Preparation of optical active hydroxy indane dione derivatives
JPS5279495A (en) Hand rail for man conveyor
SE9201201L (sv) Verktyg foer infaestning av konsoler vid ett vederlag

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20130318